Why the study?
The study evaluated the information value of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio for cardiac risk assessment in abdominal oncological surgery.
Do NLR and PLR predict cardiovascular complications and cardiac death in patients undergoing abdominal oncological surgery?
Do NLR and PLR predict cardiovascular complications and cardiac death in patients undergoing abdominal oncological surgery?
NLR and PLR are not useful predictors for perioperative cardiac risk assessment in patients undergoing abdominal oncological surgery.
Answers are grounded in this paper and cite their sources.
NLR and PLR lack predictive value for cardiac complications after abdominal oncologic surgery; hypothesis-generating and should not yet change practice.
The objective: to study information value of the neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in the cardiac risk assessment in abdominal oncological surgery. Subjects and Methods. 94 patients of 68 [62‒73] years old who underwent elective surgery were examined. Results. Cardiovascular comortbidity was diagnosed in 69 (73.4%) patients. 11 (11.7%) perioperative cardiovascular complications were registered. Cardiac mortality was 4.3%. Hematological indices were not associated with cardiovascular diseases (NLR: OR = 0.59‒1.42; 95% CI 0.14‒2.60; p = 0.29‒0.74, PLR: OR = 0.99‒1.00; 95% CI 0.97‒1.01; p = 0.31‒0.99). NLR and PLR were not predictors of cardiovascular complications (OR = 0.67; 95% CI 0.19‒2.37; p = 0.46 and OR = 1.00; 95% CI 0.99‒1.01; p = 0.68) and cardiac death (OR = 0.21; 95% CI 0.01‒8.05; p = 0.23 and OR = 0.99; 95% CI 0.98‒1.01; p = 0.79). Conclusion. NLR and PLR cannot be recommended for the cardiac risk assessment in abdominal oncological surgery.
No takes yet. Share an insight, caveat, or question.
Соколов et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: